Management of immune-related adverse events under PD-1/PD-L1 inhibitors: Insights from a Moroccan real-world experience
Early recognition and management of irAEs are essential to minimize complications and optimize outcomes. This study highlights the need for standardized protocols and enhanced monitoring in the Moroccan context.
Authors
- Mohamed Ichou (ORCID: https://orcid.org/0000-0001-6635-8505)
- Nabil Ismaili (ORCID: https://orcid.org/0000-0001-5786-5134)
- Inès Cherradi
- Mohammed Squalli Houssaini
Institutions
- Université Mohammed VI des Sciences et de la Santé (MA)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100978
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00